October 7th 2020
Alexander N. Shoushtari, discusses the rationale for the phase 3 CheckMate-067 trial in advanced melanoma.
September 22nd 2020
Alexander N. Shoushtari, MD, discusses the design of the phase 3 CheckMate-067 trial in advanced melanoma.
September 16th 2020
Alexander N. Shoushtari, MD, discusses the role of nivolumab and ipilimumab in mucosal melanoma.
November 22nd 2019
Alexander N. Shoushtari, MD, discusses the significance of the findings from the first-in-human trial evaluating tebentafusp, a TCR–CD3 bispecific, in patients with advanced melanoma.